DK3352742T3 - Præparater omfattende triterpenoider til behandling af Alzheimers sygdom og Parkinsons sygdom - Google Patents
Præparater omfattende triterpenoider til behandling af Alzheimers sygdom og Parkinsons sygdom Download PDFInfo
- Publication number
- DK3352742T3 DK3352742T3 DK16848274.3T DK16848274T DK3352742T3 DK 3352742 T3 DK3352742 T3 DK 3352742T3 DK 16848274 T DK16848274 T DK 16848274T DK 3352742 T3 DK3352742 T3 DK 3352742T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- triterpenoids
- parkinson
- alzheimer
- preparations
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title 1
- 208000018737 Parkinson disease Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 150000003648 triterpenes Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562222976P | 2015-09-24 | 2015-09-24 | |
| PCT/IL2016/051057 WO2017051423A1 (en) | 2015-09-24 | 2016-09-22 | Compositions comprising triterpenoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3352742T3 true DK3352742T3 (da) | 2022-01-10 |
Family
ID=58386370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16848274.3T DK3352742T3 (da) | 2015-09-24 | 2016-09-22 | Præparater omfattende triterpenoider til behandling af Alzheimers sygdom og Parkinsons sygdom |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10285996B2 (da) |
| EP (1) | EP3352742B1 (da) |
| JP (1) | JP7031867B2 (da) |
| KR (1) | KR20180053406A (da) |
| CN (1) | CN108289863B (da) |
| AU (1) | AU2016327288A1 (da) |
| CA (1) | CA2999822A1 (da) |
| DK (1) | DK3352742T3 (da) |
| ES (1) | ES2904263T3 (da) |
| HK (1) | HK1257366A1 (da) |
| IL (1) | IL258279B (da) |
| PL (1) | PL3352742T3 (da) |
| WO (1) | WO2017051423A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7240331B2 (ja) * | 2017-12-28 | 2023-03-15 | サントリーホールディングス株式会社 | 活性酸素産生抑制用組成物 |
| KR102583195B1 (ko) * | 2020-12-10 | 2023-09-26 | 경상국립대학교산학협력단 | 퀴노바산을 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
| CN115501261B (zh) * | 2022-10-14 | 2023-09-22 | 山西大学 | 一种藜麦糠水溶性萜类提取物及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL156976A0 (en) | 2001-02-13 | 2004-02-08 | Yissum Res Dev Co | Carotenoid-loaded liposomes |
| ATE441423T1 (de) | 2002-05-01 | 2009-09-15 | Lavipharm Sa | Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen |
| FR2867980B1 (fr) | 2004-03-23 | 2006-07-14 | Pierre Fabre Medicament Sa | Utilisation de l'acide masticadienonique en tant qu'inhibiteur de l'adn polymerase beta |
| WO2005112967A2 (en) | 2004-05-19 | 2005-12-01 | Balfour Marketing Corp. | Anticancer activity of chios mastic gum |
| WO2010032123A1 (en) * | 2008-09-19 | 2010-03-25 | Biotechnology Research Corporation Limited | Triterpenoid compounds and methods of use thereof |
| CA2754564C (en) | 2009-03-04 | 2017-09-12 | Regenera Pharma Ltd. | Therapeutic uses of mastic gum fractions |
| US8722105B2 (en) | 2009-03-04 | 2014-05-13 | Zadik Hazan | Compositions of polymeric myrcene |
| US20120027687A1 (en) | 2010-07-08 | 2012-02-02 | Alkon Daniel L | Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke |
| BR112013005300B1 (pt) * | 2010-09-07 | 2021-11-09 | Regenera Pharma Ltd | Composição que compreende extratos ácidos de goma mástique |
| EP2791189B1 (en) * | 2011-12-14 | 2018-05-02 | Ineos Europe AG | Novel polymers |
| CN103360456B (zh) | 2012-04-04 | 2015-07-29 | 浙江大学 | 三萜类化合物及制备和应用 |
| US9114130B2 (en) | 2013-05-06 | 2015-08-25 | University Of South Florida | Compounds and related methods for treatment of neurodegenerative diseases |
| CN104910238B (zh) | 2014-03-14 | 2017-08-11 | 中国科学院上海药物研究所 | 一类五环三萜类化合物及其在制备治疗阿尔兹海默病的药物中的用途 |
-
2016
- 2016-09-22 WO PCT/IL2016/051057 patent/WO2017051423A1/en not_active Ceased
- 2016-09-22 HK HK18116574.0A patent/HK1257366A1/zh unknown
- 2016-09-22 ES ES16848274T patent/ES2904263T3/es active Active
- 2016-09-22 CN CN201680068811.2A patent/CN108289863B/zh not_active Expired - Fee Related
- 2016-09-22 DK DK16848274.3T patent/DK3352742T3/da active
- 2016-09-22 EP EP16848274.3A patent/EP3352742B1/en not_active Not-in-force
- 2016-09-22 AU AU2016327288A patent/AU2016327288A1/en not_active Abandoned
- 2016-09-22 IL IL258279A patent/IL258279B/en unknown
- 2016-09-22 JP JP2018515291A patent/JP7031867B2/ja not_active Expired - Fee Related
- 2016-09-22 US US15/761,759 patent/US10285996B2/en active Active
- 2016-09-22 CA CA2999822A patent/CA2999822A1/en not_active Abandoned
- 2016-09-22 KR KR1020187011454A patent/KR20180053406A/ko not_active Ceased
- 2016-09-22 PL PL16848274T patent/PL3352742T3/pl unknown
-
2019
- 2019-03-20 US US16/359,068 patent/US10588911B2/en not_active Expired - Fee Related
-
2020
- 2020-01-23 US US16/750,472 patent/US11173164B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017051423A1 (en) | 2017-03-30 |
| JP7031867B2 (ja) | 2022-03-08 |
| CN108289863A (zh) | 2018-07-17 |
| IL258279B (en) | 2022-09-01 |
| KR20180053406A (ko) | 2018-05-21 |
| US20180264006A1 (en) | 2018-09-20 |
| ES2904263T3 (es) | 2022-04-04 |
| EP3352742A1 (en) | 2018-08-01 |
| US20200155569A1 (en) | 2020-05-21 |
| US11173164B2 (en) | 2021-11-16 |
| IL258279A (en) | 2018-05-31 |
| US10588911B2 (en) | 2020-03-17 |
| AU2016327288A1 (en) | 2018-04-12 |
| US20190209582A1 (en) | 2019-07-11 |
| US10285996B2 (en) | 2019-05-14 |
| JP2018528973A (ja) | 2018-10-04 |
| CN108289863B (zh) | 2021-03-16 |
| PL3352742T3 (pl) | 2022-05-16 |
| EP3352742A4 (en) | 2019-05-15 |
| EP3352742B1 (en) | 2021-11-03 |
| HK1257366A1 (zh) | 2019-10-18 |
| CA2999822A1 (en) | 2017-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL304429A (en) | Methods and compositions for treatment of epileptic disorders | |
| IL293783A (en) | Compounds and compositions for treating hematological disorders | |
| IL272514A (en) | Compositions and methods for modifying genomes | |
| IL283725A (en) | Compositions and methods for increasing efficiency of cardiac metabolism | |
| IL269150A (en) | Compositions and methods for treating cancer | |
| IL263224A (en) | Methods and compositions for treating cancers | |
| IL258955A (en) | Compositions and methods for treatment of cancer | |
| IL268814A (en) | Compositions and methods for treatment of cancer | |
| IL261082A (en) | Compositions and methods for modifying genomes | |
| DK3445388T3 (da) | Materialer og fremgangsmåder til behandling af hæmoglobinopatier | |
| DK3386511T3 (da) | Fremgangsmåder til behandling af huntingtons sygdom | |
| DK3789501T3 (da) | Fremgangsmåde til diagnosticering, behandling og forebyggelse af parkinsons sygdom | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3643321T3 (da) | Plasminogen til anvendelse i behandling af parkinsons og alzheimers sygdom | |
| IL252433A0 (en) | Methods for treating alzheimer's disease | |
| IL259861A (en) | Methods and compositions for the treatment of seizure-related disorders | |
| IL258259A (en) | Adjunctive therapy with 25-hydroxyvitamin d and articles therefor | |
| IL273705B (en) | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | |
| IL269157A (en) | Compositions and methods for treating cancer | |
| DK3294345T3 (da) | Tpp1-formuleringer og fremgangsmåder til behandling af cln2-sygdom | |
| IL263574A (en) | Calr and jak2 vaccine compositions | |
| DK3463351T3 (da) | Behandling til parkinsons sygdom | |
| IL264070A (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 | |
| IL256103B (en) | Compositions and methods for treating celiac sprue disease | |
| IL262508A (en) | Methods and compositions for the treatment of degenerate bone |